Abstract
In 2007, an estimated 33.2 million people were living with HIV, 2.5 million had become infected, and 2.1 million died from the virus. The majority of infected individuals reside in Africa, where in some countries as many as 33.4% of adults have HIV. In developed countries, effective drug therapies have reduced AIDS-related deaths by over seventy percent each year. These drugs have been so effective that over the last two years the global number of individuals dying from AIDS-related illness has actually declined. These therapies, however, are currently sold for $10,000 USD a year, a purchase price that is not feasible for low income countries where the annual health expenditure may be only $29 per person. A lack of essential medicine is not only a problem for those suffering from AIDS. Low and middle-income countries are disproportionately burdened by many additional chronic and infectious illnesses. The World Health Organization (“WHO”) estimates that one third of the world's population cannot regularly access essential medicines. The WHO cites the high cost of drugs as one of the major hurdles countries face in obtaining access to medication. However, the high cost of these brand-name medications does not reflect their minimal production costs. Drug manufacturers can produce generic versions of these drugs for as little as 1/30th of the cost of their brand-name counterparts.
Publisher
Cambridge University Press (CUP)
Subject
Law,General Medicine,Health (social science)
Reference13 articles.
1. The TRIPS Council's Solution to the Paragraph 6 Problem: Toward Compulsory Licensing Viability for Developing Countries;Rogers;Minn. J. Global Trade,2004
2. Pledges and Pitfalls: Canada's Legislation on Compulsory Licensing of Pharmaceuticals for Export;Elliot;Int’l J. Intellectual Prop. Mgmt.,2006
3. Pharmaceutical Arbitrage: Balancing Access and Innovation in International Prescription Drug Markets;Outterson;Yale J. Health Pol'y L. and Ethics,2005
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献